Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3726)
All Articles published online
|
Apr 27, 2011 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Doycheva I, Chen C, Pan JJ, Levy C. Asymptomatic primary biliary cirrhosis is not associated with increased frequency of cardiovascular disease. World J Hepatol 2011; 3(4): 93-98 [PMID: 21603031 DOI: 10.4254/wjh.v3.i4.93] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v3/i4/93.htm |
| Number | Citing Articles |
| 1 |
Michael Trauner, Frederik Nevens, Mitchell L Shiffman, Joost P H Drenth, Christopher L Bowlus, Victor Vargas, Pietro Andreone, Gideon M Hirschfield, Richard Pencek, Elizabeth Smoot Malecha, Leigh MacConell, David Shapiro. Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study. The Lancet Gastroenterology & Hepatology 2019; 4(6): 445 doi: 10.1016/S2468-1253(19)30094-9
|
| 2 |
Jesús David Sendoya Vargas, María Camila Gutiérrez Vargas, Christian Ernesto Melgar Burbano. Riesgo cardiovascular en personas con colangitis biliar primaria, revisión de la literatura. Revista Med 2024; 32(1): 63 doi: 10.18359/rmed.6929
|
| 3 |
Ramona Nicolau‐Raducu, Marina Gitman, Donald Ganier, George E. Loss, Ari J. Cohen, Hamang Patel, Nigel Girgrah, Krish Sekar, Bobby Nossaman. Adverse cardiac events after orthotopic liver transplantation: A cross‐sectional study in 389 consecutive patients. Liver Transplantation 2015; 21(1): 13 doi: 10.1002/lt.23997
|
| 4 |
P. Loria, G. Marchesini, F. Nascimbeni, S. Ballestri, M. Maurantonio, F. Carubbi, V. Ratziu, A. Lonardo. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. Atherosclerosis 2014; 232(1): 99 doi: 10.1016/j.atherosclerosis.2013.10.030
|
| 5 |
Aurora Marina Loaeza-del Castillo, Alhely Gaytán-Santillán, Alma López-Tello, Merit Valdés-Almanza Merit, María del Pilar Milke-García, Jorge Flores-Rodríguez, Ulices Alvirde-García. Patterns of serum lipids derangements and cardiovascular risk assessment in patients with primary biliary cholangitis. Annals of Hepatology 2019; 18(6): 879 doi: 10.1016/j.aohep.2019.07.006
|
| 6 |
Patompong Ungprasert, Karn Wijarnpreecha, Charat Thongprayoon. Risk of cerebrovascular accident in patients with primary biliary cirrhosis. European Journal of Gastroenterology & Hepatology 2016; 28(1): 90 doi: 10.1097/MEG.0000000000000493
|
| 7 |
Patompong Ungprasert, Karn Wijarnpreecha, Wasin Ahuja, Ittikorn Spanuchart, Charat Thongprayoon. Coronary artery disease in primary biliary cirrhosis: A systematic review and meta‐analysis of observational studies. Hepatology Research 2015; 45(11): 1055 doi: 10.1111/hepr.12452
|
| 8 |
Martin I Wah-Suarez, Christopher J Danford, Vilas R Patwardhan, Z Gordon Jiang, Alan Bonder. Hyperlipidaemia in primary biliary cholangitis: treatment, safety and efficacy. Frontline Gastroenterology 2019; 10(4): 401 doi: 10.1136/flgastro-2018-101124
|
| 9 |
Bumsoo Park, Sumaiya Islam, Raghavendra C. Vemulapalli, Maria E. Shreve. Primary biliary cholangitis presenting as acute ischemic stroke: A rare association. Clinical Case Reports 2020; 8(2): 274 doi: 10.1002/ccr3.2590
|
| 10 |
William J. Cash, Stephen O'Neill, Mark E. O'Donnell, David R. McCance, Ian S. Young, Jane McEneny, Neil I. McDougall, Michael E. Callender. Randomized controlled trial assessing the effect of simvastatin in primary biliary cirrhosis. Liver International 2013; 33(8): 1166 doi: 10.1111/liv.12191
|
| 11 |
Jakob Höppner, Christoph Tabeling, Vincent Casteleyn, Claudia Kedor, Wolfram Windisch, Gerd Rüdiger Burmester, Dörte Huscher, Elise Siegert. Comprehensive autoantibody profiles in systemic sclerosis: Clinical cluster analysis. Frontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.1045523
|
| 12 |
Duminda Suraweera, Christina Fanous, Melissa Jimenez, Myron J. Tong, Sammy Saab. Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review. Journal of Clinical and Translational Hepatology 2018; 6(2): 1 doi: 10.14218/JCTH.2017.00064
|
| 13 |
Shaifali Sandal, Tianyan Chen, Marcelo Cantarovich. The Challenges With the Cardiac Evaluation of Liver and Kidney Transplant Candidates. Transplantation 2020; 104(2): 251 doi: 10.1097/TP.0000000000002951
|
| 14 |
Mo Lee Wong, Rajeev P Raghavan, Neil A Hedger, Richard D Ellis, Darryl R Meeking, Lorraine Albon. The use of plasmapheresis in managing primary biliary cirrhosis presenting with profound hypercholesterolaemia. The British Journal of Diabetes & Vascular Disease 2012; 12(3): 156 doi: 10.1177/1474651412442410
|
| 15 |
Jianping Xiong, Weiyu Xu, Hanchun Huang, Jin Bian, Anqiang Wang, Yi Bai, Jianzhen Lin, Yiyao Xu, Xin Lu, Haitao Zhao. Cirrhosis and risk of stroke: A systematic review and meta-analysis. Atherosclerosis 2018; 275: 296 doi: 10.1016/j.atherosclerosis.2018.06.876
|